News in the Life Sciences Industry

NEW YORK, June 18, 2019 /PRNewswire/ --

About this market

The global pericarditis drugs market is currently witnessing a high patient pool seeking treatment for the disease. Pericarditis is the most commonly occurring disease of the pericardium. It is the cause for... Read more ››

STATESVILLE, N.C., June 18, 2019 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2019.

NEW YORK, June 18, 2019 /PRNewswire/ --

The report on the global monoclonal antibody therapeutics market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

PRINCETON, N.J., June 18, 2019 /PRNewswire/ -- Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and solutions for diagnostic and interventional imaging today announced a group purchasing agreement with Premier Inc., a leading healthcare improvement company... Read more ››

SAN DIEGO, June 18, 2019 /PRNewswire/ -- Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed ORM-12741 from Orion Corporation. Denovo gains global rights to develop, manufacture and commercialize ORM-12741.

NEW YORK, June 18, 2019 /PRNewswire/ -- Diabetes nonprofit organization Beyond Type 1 has been named an Official Charity Partner of the 2019 TCS New York City Marathon. 2019 will be Beyond Type 1's third consecutive year running NYC, fielding a team of 30 runners each living with Type... Read more ››

NEW YORK, June 18, 2019 /PRNewswire/ -- INTRODUCTION

Over the years, the biopharmaceutical market has grown into a prominent and promising segment of the overall pharmaceutical industry. Characterized by a number of blockbuster therapies (Humira, Rituxan, Lantus, Avastin, Herceptin... Read more ››

SAN DIEGO, June 18, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the BMO 2019 Prescriptions for... Read more ››

NEWARK, Calif., June 18, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 17, 2019, it issued an inducement award to Nishit Modi, Ph.D., the Company's recently hired Vice President of Clinical Pharmacology, in accordance with the terms of Dr. Modi's... Read more ››

FAIRFIELD, N.J., June 18, 2019 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. today announced that the Company is in discussions for various financing options to advance MM36 (difamilast) through phase 3 pivotal trials and potential FDA approval. As part of this process, the Company extinguished... Read more ››

NEW YORK, June 18, 2019 /PRNewswire/ --